Jubb, B., Lewis, M., McFadyen, L., Simpson, P., Mori, J., Chan, P., . . . Craig, C. (2019). Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials. Antivir Chem Chemother.
Chicago ZitierstilJubb, Becky, et al. "Incidence of CXCR4 Tropism and CCR5-tropic Resistance in Treatment-experienced Participants Receiving Maraviroc in the 48-week MOTIVATE 1 and 2 Trials." Antivir Chem Chemother 2019.
MLA ZitierstilJubb, Becky, et al. "Incidence of CXCR4 Tropism and CCR5-tropic Resistance in Treatment-experienced Participants Receiving Maraviroc in the 48-week MOTIVATE 1 and 2 Trials." Antivir Chem Chemother 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.